Literature DB >> 16485149

The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration or age association?

Michael Schaapveld1, Elisabeth G E de Vries, Winette T A van der Graaf, Renée Otter, Jakob de Vries, Pax H B Willemse.   

Abstract

BACKGROUND: The number of pathologically examined axillary nodes has been associated with breast cancer survival, and examination of >or=10 nodes has been advocated for reliable axillary staging. The considerable variation observed in axillary staging prompted this population-based study, which evaluated the prognostic effect of a variable number of pathologically examined nodes.
METHODS: In total, 5314 consecutive breast cancer patients who underwent mastectomy or breast-conserving surgery and axillary dissection between 1994 and 1999 were included. The prognostic effect of the examined number of nodes was assessed with crude and relative survival analysis.
RESULTS: A median number of 12 (range, 1-43) nodes were histologically examined, and 59% of the patients had no nodal tumor involvement. The number of examined nodes decreased with age (P<.001) and increased with tumor size (P<.001). Stratified for the number of tumor-positive nodes, overall survival seemed to be worse for patients with <10 compared with patients with >or=10 examined nodes (P<.001), whereas the relative survival did not differ. After adjusting for age, tumor size, number of positive nodes, and detection by screening in a multivariate analysis, the number of examined nodes was not associated with relative survival.
CONCLUSIONS: This study shows that the association between the number of pathologically examined axillary nodes and overall survival in node-negative and node-positive patients results from stage migration. The absence of an association between the number of examined nodes and relative survival further indicates that the association between the number of examined nodes and crude survival is confounded by age.

Entities:  

Mesh:

Year:  2006        PMID: 16485149     DOI: 10.1245/ASO.2006.02.020

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  Number of negative lymph nodes should be considered for incorporation into staging for breast cancer.

Authors:  San-Gang Wu; Yan Wang; Juan Zhou; Jia-Yuan Sun; Feng-Yan Li; Huan-Xin Lin; Zhen-Yu He
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal Cancer.

Authors:  Joshua E Meyer; Steven J Cohen; Karen J Ruth; Elin R Sigurdson; Michael J Hall
Journal:  J Natl Cancer Inst       Date:  2016-01       Impact factor: 13.506

3.  Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2,151 patients.

Authors:  Nüvit Duraker; Bakir Bati; Zeynep Civelek Çaynak; Davut Demir
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

4.  Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1-3 Axillary Lymph Node(s) Metastasis.

Authors:  Nüvit Duraker; Bakır Batı; Davut Demir; Zeynep Civelek Caynak
Journal:  ISRN Oncol       Date:  2011-10-12

5.  Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer.

Authors:  San-Gang Wu; Jia-Yuan Sun; Juan Zhou; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Xun-Xing Guan; Zhen-Yu He
Journal:  BMC Cancer       Date:  2015-02-07       Impact factor: 4.430

6.  Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.

Authors:  San-Gang Wu; Jia-Yuan Sun; Juan Zhou; Feng-Yan Li; Hao Zhou; Qin Lin; Huan-Xin Lin; Yong Bao; Zhen-Yu He
Journal:  Radiat Oncol       Date:  2014-12-16       Impact factor: 3.481

7.  The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC).

Authors:  Ji Yun Lee; Sung Hee Lim; Min-Young Lee; Hae Su Kim; Jin Seok Ahn; Young-Hyuck Im; Yeon Hee Park
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

8.  Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma.

Authors:  Hansheng Wu; Weitao Zhuang; Shujie Huang; Xueting Guan; Yuju Zheng; Zefeng Xie; Gang Chen; Jiming Tang; Haiyu Zhou; Liang Xie; Xiaosong Ben; Zihao Zhou; Zijun Li; Rixin Chen; Guibin Qiao
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

9.  Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer.

Authors:  Jiahuai Wen; Feng Ye; Xiaofang He; Shuaijie Li; Xiaojia Huang; Xiangsheng Xiao; Xiaoming Xie
Journal:  Oncotarget       Date:  2016-04-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.